We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OHI icon
326
Omega Healthcare
OHI
$15.4B
$182K ﹤0.01%
4,971
-142
-3% -$5.27K
VRNA
327
DELISTED
Verona Pharma
VRNA
$179K ﹤0.01%
1,894
-7,870
-81% -$583K
BXP icon
328
Boston Properties
BXP
$11.2B
$179K ﹤0.01%
2,653
-192
-7% -$12.8K
CUBE icon
329
CubeSmart
CUBE
$9.62B
$172K ﹤0.01%
4,038
-245
-6% -$10.2K
HALO icon
330
Halozyme
HALO
$9.9B
$169K ﹤0.01%
3,258
MDGL icon
331
Madrigal Pharmaceuticals
MDGL
$12.4B
$169K ﹤0.01%
558
MBLY icon
332
Mobileye
MBLY
$2.13B
$167K ﹤0.01%
+9,312
New +$142K
CRSP icon
333
CRISPR Therapeutics
CRSP
$4.68B
$165K ﹤0.01%
3,401
+1,215
+56% +$47K
GH icon
334
Guardant Health
GH
$19B
$165K ﹤0.01%
3,164
JAZZ icon
335
Jazz Pharmaceuticals
JAZZ
$16.1B
$164K ﹤0.01%
1,548
DVA icon
336
DaVita
DVA
$15.4B
$163K ﹤0.01%
1,142
-8
-0.7% -$1.13K
IONS icon
337
Ionis Pharmaceuticals
IONS
$9.14B
$160K ﹤0.01%
4,042
RCL icon
338
Royal Caribbean
RCL
$86.5B
$159K ﹤0.01%
+508
New +$121K
RVMD icon
339
Revolution Medicines
RVMD
$39.1B
$158K ﹤0.01%
4,307
PONY
340
Pony AI Inc
PONY
$3.29B
$158K ﹤0.01%
+11,978
New +$145K
EGP icon
341
EastGroup Properties
EGP
$11.3B
$154K ﹤0.01%
922
-16
-2% -$2.66K
REXR icon
342
Rexford Industrial Realty
REXR
$8.64B
$148K ﹤0.01%
4,166
-46
-1% -$1.6K
NNN icon
343
NNN REIT
NNN
$9.37B
$143K ﹤0.01%
3,317
-235
-7% -$9.76K
BRX icon
344
Brixmor Property Group
BRX
$9.77B
$141K ﹤0.01%
5,398
-323
-6% -$8.21K
ADC icon
345
Agree Realty
ADC
$9.74B
$138K ﹤0.01%
1,894
-67
-3% -$5.04K
VTLE
346
DELISTED
Vital Energy
VTLE
$137K ﹤0.01%
8,524
+532
+7% +$8.7K
FRT icon
347
Federal Realty Investment Trust
FRT
$10.9B
$137K ﹤0.01%
1,437
-11
-0.8% -$1.04K
COIN icon
348
Coinbase
COIN
$44.2B
$132K ﹤0.01%
378
+344
+1,012% +$80.4K
AXSM icon
349
Axsome Therapeutics
AXSM
$12.1B
$130K ﹤0.01%
1,241
NUVL
350
DELISTED
Nuvalent
NUVL
$128K ﹤0.01%
1,680

Similar funds

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.